Funding for this research was provided by:
Hjärt-Lungfonden (20140633, 20030595)
Region Östergötland (LIO-693091, LIO-443891)
Received: 24 August 2020
Accepted: 4 May 2021
First Online: 13 July 2021
: Ethical approval for this substudy to the GLUTAMICS trial (original protocol no M76-05; addendum 26-07) was provided by the Regional Ethical Review Board in Linköping, Sweden. It was performed according to the Helsinki Declaration of Human Rights and the patients were enrolled in the study after written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.